HomeCompareEXC vs ALGN

EXC vs ALGN: Dividend Comparison 2026

EXC yields 3.30% · ALGN yields 1.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXC wins by $4.8K in total portfolio value
10 years
EXC
EXC
● Live price
3.30%
Share price
$49.11
Annual div
$1.62
5Y div CAGR
4.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.2K
Annual income
$671.89
Full EXC calculator →
ALGN
ALGN
● Live price
1.20%
Share price
$166.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$130.06
Full ALGN calculator →

Portfolio growth — EXC vs ALGN

📍 EXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXCALGN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXC + ALGN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXC pays
ALGN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXC
Annual income on $10K today (after 15% tax)
$280.39/yr
After 10yr DRIP, annual income (after tax)
$571.11/yr
ALGN
Annual income on $10K today (after 15% tax)
$102.25/yr
After 10yr DRIP, annual income (after tax)
$110.55/yr
At 15% tax rate, EXC beats the other by $460.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXC + ALGN for your $10,000?

EXC: 50%ALGN: 50%
100% ALGN50/50100% EXC
Portfolio after 10yr
$23.8K
Annual income
$400.97/yr
Blended yield
1.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ALGN right now

EXC
Analyst Ratings
17
Buy
16
Hold
2
Sell
Consensus: Buy
Price Target
$50.55
+2.9% upside vs current
Range: $39.00 — $57.00
Altman Z
0.8
Piotroski
5/9
ALGN
Analyst Ratings
24
Buy
7
Hold
2
Sell
Consensus: Buy
Price Target
$197.30
+18.7% upside vs current
Range: $140.00 — $220.00
Altman Z
4.9
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXC buys
0
ALGN buys
9
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$ALGN▼ Sell$1,001 - $15,0002025-09-11
Lisa McClain🏢 House$ALGN▲ Buy$1,001 - $15,0002025-08-04
Rob Bresnahan🏢 House$ALGN▼ Sell$1,001 - $15,0002025-04-08
Gilbert Cisneros🏢 House$ALGN▼ Sell$1,001 - $15,0002025-02-26
Rob Bresnahan🏢 House$ALGN▲ Buy$1,001 - $15,0002025-02-25
Ro Khanna🏢 House$ALGN▲ Buy$1,001 - $15,0002024-09-09
Ro Khanna🏢 House$ALGN▲ Buy$1,001 - $15,0002024-09-09
Josh Gottheimer🏢 House$ALGN▼ Sell$1,001 - $15,0002024-05-20
Ro Khanna🏢 House$ALGN▲ Buy$1,001 - $15,0002024-02-13
Ro Khanna🏢 House$ALGN▲ Buy$1,001 - $15,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXCALGN
Forward yield3.30%1.20%
Annual dividend / share$1.62$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR4.6%0%
Portfolio after 10y$26.2K$21.4K
Annual income after 10y$671.89$130.06
Total dividends collected$4.9K$1.3K
Payment frequencyquarterlyquarterly
SectorUtilitiesStock
Analyst consensusBuyBuy
Analyst price target$50.55$197.30

Year-by-year: EXC vs ALGN ($10,000, DRIP)

YearEXC PortfolioEXC Income/yrALGN PortfolioALGN Income/yrGap
1← crossover$11,045$345.05$10,820$120.29+$225.00EXC
2$12,191$372.56$11,699$121.65+$492.00EXC
3$13,446$401.98$12,641$122.92+$805.00EXC
4$14,821$433.43$13,650$124.13+$1.2KEXC
5$16,325$467.02$14,731$125.27+$1.6KEXC
6$17,971$502.89$15,889$126.34+$2.1KEXC
7$19,770$541.17$17,128$127.36+$2.6KEXC
8$21,736$581.99$18,455$128.31+$3.3KEXC
9$23,883$625.51$19,876$129.21+$4.0KEXC
10$26,227$671.89$21,398$130.06+$4.8KEXC

EXC vs ALGN: Complete Analysis 2026

EXCUtilities

Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services. Additionally, it is involved in the purchase and regulated retail sale of electricity and natural gas; and transmission and distribution of electricity, and distribution of natural gas to retail customers. Further, the company offers support services, including legal, human resources, information technology, financial, supply management, accounting, engineering, customer operations, distribution and transmission planning, asset management, system operations, and power procurement services. It serves distribution utilities, municipalities, cooperatives, and financial institutions, as well as commercial, industrial, governmental, and residential customers. Exelon Corporation was incorporated in 1999 and is headquartered in Chicago, Illinois.

Full EXC Calculator →

ALGNStock

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Full ALGN Calculator →
📬

Get this EXC vs ALGN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXC vs SCHDEXC vs JEPIEXC vs OEXC vs KOEXC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.